Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of ARQ-151 Cream 0.3% in Chronic Plaque Psoriasis
NCT04286607Phase 3Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Feb 2020
- Primary completion
- Jan 2024
- Countries
- 3
01
Overview
A Phase 3 trial of roflumilast vehicle cream in psoriasis, sponsored by Arcutis Biotherapeutics. Started Feb 2020; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04286607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04286607.